Matches in Nanopublications for { ?s ?p "[KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP868140.RArh_mz9X19KhH8FyEc2ZAvLC6rOFFHypGEqIlPv2Rx4o130_assertion description "[KRAS-mutated non-small cell lung cancer cells are responsive to either co-treatment with erlotinib or gefitinib and histone deacetylase inhibitors or single treatment with lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868140.RArh_mz9X19KhH8FyEc2ZAvLC6rOFFHypGEqIlPv2Rx4o130_provenance.